Agota Csoti Selected Research

Alzheimer Disease (Alzheimer's Disease)

5/2021

Lipopolysaccharide influences the plasma and brain pharmacokinetics of subcutaneously-administered HsTX1[R14A], a KV1.3-blocking peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agota Csoti Research Topics

Disease

3	Neuroinflammatory Diseases 01/2023 - 05/2021
2	Inflammation (Inflammations) 01/2023 - 11/2022
1	Multiple Sclerosis 11/2022
1	Rheumatoid Arthritis 11/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022
1	Osteosarcoma (Osteogenic Sarcoma) 09/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 05/2021
1	Parkinson Disease (Parkinson's Disease) 05/2021
1	Atrial Fibrillation 01/2020
1	Drug Resistant Epilepsy 01/2018
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2018
1	Seizures (Absence Seizure) 01/2018

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 01/2023 - 01/2018
3	LipopolysaccharidesIBA 01/2023 - 05/2021
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 11/2022 - 05/2021
2	VenomsIBA 01/2020 - 01/2018
1	CytokinesIBA 01/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2023
1	cyanine dye 5IBA 11/2022
1	MineralsIBA 09/2022
1	AstemizoleIBA 09/2022
1	Ion Channels (Ion Channel)IBA 09/2022
1	Voltage-Gated Sodium ChannelsIBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2020
1	Intraventricular Infusions 01/2018
1	Precision Medicine 01/2018